Jurczyszyn A - Search Results

1

Therapeutic adherence and assessment of satisfaction patients with multiple myeloma treated with immunomodulatory drugs in a "real-world" study: Experiences of the Polish Myeloma Group.

Charliński G, Grząśko N, Bołkun Ł, Sawicki W, Paczkowska E, Druzd-Sitek A, Usnarska-Zubkiewicz L, Butrym A, Wiater E, Boguradzki P, Budziszewska B, Wojciechowska M, Mordak-Domagała M, Jurczyszyn A. Charliński G, et al. Among authors: jurczyszyn a. J Oncol Pharm Pract. 2024 Oct;30(7):1144-1151. doi: 10.1177/10781552231203371. Epub 2023 Sep 20. J Oncol Pharm Pract. 2024. PMID: 37728209

2

Efficacy and safety of stem cell mobilization with cyclophosphamide plus etoposide versus cyclophosphamide alone.

Jurczyszyn A, Vesole DH, Gdula-Argasińska J, Giza A, Zawirska D, Baster J, Walter Z, Węglarska D, Dadej A, Castillos JJ, Skotnicki AB. Jurczyszyn A, et al. Przegl Lek. 2015;72(11):606-10. Przegl Lek. 2015. PMID: 27012116

3

Intraoral manifestation of systemic AL amyloidosis with unique microscopic presentation of intracellular amyloid deposition in striated muscles.

Oruba Z, Kaczmarzyk T, Urbańczyk K, Jurczyszyn A, Fornagiel S, Gałązka K, Bednarczyk A, Chomyszyn-Gajewska M. Oruba Z, et al. Among authors: jurczyszyn a. Pol J Pathol. 2018;69(2):200-204. doi: 10.5114/pjp.2018.76705. Pol J Pathol. 2018. PMID: 30351869 Free article.

4

Interaction between functional polymorphisms in FCER1A and TLR2 and the severity of atopic dermatitis.

Potaczek DP, Przytulska-Szczerbik A, Bazan-Socha S, Nastałek M, Wojas-Pelc A, Okumura K, Nishiyama C, Jurczyszyn A, Undas A, Wypasek E. Potaczek DP, et al. Among authors: jurczyszyn a. Hum Immunol. 2020 Dec;81(12):709-713. doi: 10.1016/j.humimm.2020.08.002. Epub 2020 Sep 1. Hum Immunol. 2020. PMID: 32883546

5

Docosahexaenoic acid regulates gene expression in HUVEC cells treated with polycyclic aromatic hydrocarbons.

Gdula-Argasińska J, Czepiel J, Totoń-Żurańska J, Jurczyszyn A, Perucki W, Wołkow P. Gdula-Argasińska J, et al. Among authors: jurczyszyn a. Toxicol Lett. 2015 Jul 16;236(2):75-81. doi: 10.1016/j.toxlet.2015.05.002. Epub 2015 May 5. Toxicol Lett. 2015. PMID: 25956473

6

[Multiple myeloma: the role of angiogenesis and therapeutic application of thalidomide].

Jurczyszyn A, Wolska-Smoleń T, Skotnicki AB. Jurczyszyn A, et al. Przegl Lek. 2003;60(8):542-7. Przegl Lek. 2003. PMID: 14974349 Review. Polish.

7

Bone marrow suppression with plasma cell leukemia‑like reaction complicated by macrophage activation syndrome after metamizole overuse.

Jurczyszyn A, Engel A, Bazan-Socha S, Czepiel J, Biesiada G, Skotnicki AB. Jurczyszyn A, et al. Pol Arch Med Wewn. 2013;123(5):257-8. Pol Arch Med Wewn. 2013. PMID: 23722194 Free article. No abstract available.

8

[Waldenström's macroglobulinemia--the experts opinion about new therapeutic possibilities and response criteria].

Jurczyszyn A, Skotnicki AB. Jurczyszyn A, et al. Pol Arch Med Wewn. 2004 Sep;112(3):1113-21. Pol Arch Med Wewn. 2004. PMID: 15727094 Review. Polish. No abstract available.

9

Clostridium difficile caused changes in fatty acids profile and resolvin D1 content in plasma of infected patients.

Dróżdż M, Gdula-Argasińska J, Biesiada G, Jurczyszyn A, Perucki W, Wołkow P, Borys A, Sroczyńska K, Zając A, Librowski T, Garlicki A, Czepiel J. Dróżdż M, et al. Among authors: jurczyszyn a. Eur J Gastroenterol Hepatol. 2020 Mar;32(3):318-324. doi: 10.1097/MEG.0000000000001600. Eur J Gastroenterol Hepatol. 2020. PMID: 31714390

10

[Progress in the diagnosis and treatment of cardiac amyloidosis].

Jurczyszyn A, Engel A, Rajzer M, Czepiel J, Mazurs G. Jurczyszyn A, et al. Przegl Lek. 2014;71(6):340-5. Przegl Lek. 2014. PMID: 25344976 Review. Polish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters